GLP-1 Medications: A New Hope for Reducing Alcohol Consumption
- Research shows that certain diabetes medications, called GLP-1 receptor agonists, may help decrease alcohol consumption.
- Mohsen Subhani from the University of Nottingham, was published in eClinicalMedicine.
- This research suggests that diabetes medications may help people, particularly those with obesity, reduce their alcohol intake by targeting areas of the brain involved in reward pathways.
Diabetes Medications May Help Reduce Alcohol Consumption
Research shows that certain diabetes medications, called GLP-1 receptor agonists, may help decrease alcohol consumption. A study analyzed data from over 88,000 participants, finding significant benefits for some individuals, especially those with obesity.
The research, led by Dr. Mohsen Subhani from the University of Nottingham, was published in eClinicalMedicine. The study focused on GLP-1 receptor agonists to determine their impact on alcohol intake.
Key Findings:
- One study found that exenatide did not greatly lower drinking levels overall after six months. However, individuals with obesity showed some positive outcomes.
- Another study showed that individuals taking dulaglutide were 29% more likely to reduce their alcohol consumption compared to those on a placebo.
- Observational studies indicated that users of GLP-1 receptor agonists had fewer alcohol-related health issues than those receiving other treatments.
This research suggests that diabetes medications may help people, particularly those with obesity, reduce their alcohol intake by targeting areas of the brain involved in reward pathways.
For more details, see the reference: “Association between glucagon-like peptide-1 receptor agonists use and change in alcohol consumption: a systematic review” by Mohsan Subhani et al., published on November 14, 2024, in eClinicalMedicine. DOI: 10.1016/j.eclinm.2024.102920.